Joëlle Monnet, MSc

Fresenius Kabi SwissBioSim
Eysins, Switzerland

Joëlle Monnet graduated in Biostatistics in 2001 from the ENSAI (French National School for Statistics and Analysis of data Information), with a secondary focus on Epidemiology and Public Health. She is a medical statistician with 20 years’ experience in biostatistics applied to drug development. She is currently a Director in Biostatistics in the Biopharmaceutical Business Unit at Fresenius Kabi Swiss BioSim, focusing on biosimilars development for auto-immune diseases.

Disclosure information not submitted.

Presentation(s):

• 1432: Pharmacokinetic Evaluation of a Proposed Adalimumab Biosimilar MSB11022 versus the US-Licensed Reference Product: Results of a Randomized, Double-Blind, 3-Arm Parallel-Group, Single-Dose Trial in Healthy Subjects

  Sunday, November 13, 2022
  1:00 PM – 3:00 PM Eastern Time